Over 70% Of Studies Back Medical Cannabis In Cancer Treatment: A Sweeping Meta-Analysis
A medical cannabis cancer treatment meta-analysis found that over 70% of studies demonstrate clinical benefit. This meta-analysis supports cannabis use in oncology for symptom management. The findings highlight cannabis's role in cancer supportive care.
Evaluating FABP5 as a Therapeutic Target for Pain Management.
FABP5 pain management is emerging as a promising non-opioid approach to analgesia. Pharmacological inhibition of FABP5 shows analgesic effects in preclinical pain models. This target modulates cannabinoid receptor signaling, offering new insights into…
Chinese Researchers Develop Cannabis-Based Molecule with Strong Pain Relief, Fewer Side Effects
Synthetic cannabinoid development is a promising area for pain relief with fewer side effects. Chinese researchers have created a novel cannabis-based molecule showing strong analgesic potential. This development could expand treatment options for…
Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients
Medical cannabis counseling is increasingly important for older adults as many seek advice on pain, sleep, and anxiety. Physicians often feel underprepared to provide detailed, age-specific guidance. This study highlights the growing need for better…
Cannabis Boom: Innovations Rise, Health Gains Lag Behind
The clinical cannabis evidence gap highlights the disconnect between rapid product innovations and limited health gains. Despite industry growth, clinical trials supporting therapeutic efficacy remain scarce. Clinicians must navigate this gap carefully…
Dallas Hemp Shops React to Texas Hemp Regulations Impact
Texas hemp regulations impact patient access to delta-8 THC products used for symptom management. Regulatory uncertainty creates challenges for patients relying on these cannabinoids. Dallas hemp shops react to the stalled Texas THC ban and its effects…
Virginia’s Hemp Crackdown and the Return of Prohibition | Cato at Liberty Blog
Virginia hemp enforcement changes directly affect patient access to hemp-derived CBD products. These changes create clinical uncertainty about product availability and legal status. Healthcare providers should monitor these developments closely.
Daily Temporal Associations Between Psychoactive Substance Use and MS Symptoms
This study investigates psychoactive substance use multiple sclerosis patients experience daily. Using ecological momentary assessment, it tracks symptom fluctuations and substance use patterns. Findings reveal complex, symptom-dependent relationships…
Cannabinoid Clinical Evidence and Its Role in Chronic Pain Management
Current cannabinoid clinical evidence shows modest benefits primarily for neuropathic pain in chronic pain management. The evidence base remains thin with ongoing research gaps. Understanding this cannabinoid clinical evidence is essential for informed…
Medical Cannabis Can Provide Sustained Relief for Migraines – NORML
This longitudinal study medical cannabis migraine research provides evidence for sustained therapeutic benefit beyond acute relief. Migraine affects 12% of the population with limited effective treatments. The study highlights cannabis as a promising…